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Abstract: Ten free-living elderly were administered with a synbiotic [fermented milk containing Lactobacillus rhamnosus Gorbach and 
Goldin (LGG®)] and oligofructose as a prebiotic for one month. Serum cytokines were evaluated before (T0) and after (T1) synbiotic 
administration. At T0, values of Interleukin (IL)-12, IL-6, IL-10, IL-1 and Tumor Necrosis Factor (TNF)- were lower than normal 
controls, with the exception of IL-8, thus confirming previous results on the impairment of both innate and adaptive responses in elderly. 
At T1, the synbiotic was able to significantly increase, depressed values of IL-1, IL-6 and IL-8 with a trend to a modest increase for the 
restant cytokines. 
In conclusion, the synbiotic used in this study seems to be very beneficial to elderly for its capacity to maintain the immune homeostasis, 
even if an increase in dosage and prolongation of administration time are required for a better modulation of the aged adaptive immune 
response.   
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INTRODUCTION 
 Probiotics and, in particular, lactobacilli and bifidobacteria have 
been shown to exert beneficial effects when administered to 
humans [1]. Once ingested, they reach the ileum and compete with 
pathogens for nutrients, also rendering the intestinal habitat hostile 
for microbes via their metabolites such as short chain fatty acids 
(SCFA) [1]. 
 Nowadays, clinical studies with probiotics are numerous and 
many evidences support their beneficial role in respiratory 
infections [2], diarrhea [3,4], inflammatory bowel disease [5-8] and 
allergy [9,10,11-13]. 
 Special attention has been devoted to elderly in terms of therapy 
with probiotics. In fact, aged people undergo a progressive decline 
of immune functions and, therefore, they are more susceptible to 
infections [14]. In this framework, there are evidences on the ability 
of probiotics to shorten the duration of winter infections in elderly 
and of respiratory infections [15,16]. 
 Even if many studies have been conducted on the effects of 
probiotics on the immune system, the mechanisms by which they 
modulate immune responsiveness are still under study. 
 According to Shida and Nanno [17], three main pathways of 
probiotic-mediated immune modulation can be hypothesized: 
• M cells within Peyer’s patches (PP) take up probiotics via 
transcytosis and present them to antigen presenting cells 
(APCs), such as macrophages (MØ) and dendritic cells (DCs) 
placed immediately below the intestinal epithelium; 
• DCs in the intestinal lamina propria project their ramifications 
between intestinal epithelial cells (IECs),thus engulfing and 
processing probiotics; 
• Probiotics interact with IECs which, in turn, activate MØ, 
DCs, T and B cells in the context of PP via release of 
cytokines [e.g., T helper (h)-1 induction was promoted by IL-
12 from APC stimulated by lactobacilli]. 
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 T regulatory (Treg) cells seem to play a paramount role in the 
regulation of immune response after dietary administration of 
probiotics. In this respect, evidence has been provided that 
probiotics favor the conversion of immature DCs to regulatory 
DCs, thus leading to the induction of IL-10 producing Treg cells 
[18,19]. In this direction, another important target of therapy with 
probiotics is represented by IL-17 producing Th cells (Th 17 cells), 
which are involved in the pathogenesis of autoimmune and chronic 
inflammatory diseases [20]. In fact, Th1 and Treg cells induction by 
probiotics could inhibit Th17 activity, thus leading to an impro-
vement of clinical manifestations in the course of autoimmune and 
inflammatory pathologies. 
 In terms of dietary compounds endowed with beneficial effects, 
prebiotics represent non digestible food constituents able to 
promote growth and activity of probiotics in the intestine [17]. At 
the same time, there is evidence that consumption of highly 
fermentable dietary fibers leads to modulation of both intestinal 
immune system and flora via production of SCFA. In particular, 
propionate and butyrate as SCFA maintain the health of gut 
epithelium, thus reducing the risk of inflammatory and neoplastic 
development in the bowel [21]. 
 Synbiotics are a mixture of probiotics and prebiotics able to 
potentiate each other, thus increasing the activity of the single 
components. For instance, Bifidobacterium lactis HNO19 combined 
with the prebiotic galactooligosaccharide could increase lactobacilli 
and bifidobacteria in feces more than the probiotic and the prebiotic 
did as single components [22]. Moreover, Kanamori and associates 
[23] reported that a synbiotic (B. breve, Lactobacillus casei Shirota 
and galactoligoosaccharide) ameliorated the clinical manifestations 
in short bowel patients in terms of weight gain. On the other hand, 
clinical trials in elderly with prebiotics alone gave rise to 
conflicting results such as reduction of phagocytic activity and IL-6 
mRNA expression [24] and no effect on the vaccination with viral 
and bacterial antigens [25]. 
 Based on these last concepts, aim of this study was to evaluate 
the administration of a synbiotic (fermented milk containing 
Lactobacillus rhamnosus and the soluble fibers oligofructose) to 
free-living elderly. Serum cytokine modifications following 
synbiotic administration were recorded. 
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SUBJECTS AND METHODS 
 Ten free-living aged people (age range 69-96) were recruited 
from the Geriatric Center “Mamma Rosa”, Turi (Italy). 
 An informed consent was obtained from all participants to the 
study. 
 Aged subjects were selected according to the following criteria:  
• Absence of major diseases (metabolic, cardiovascular, 
autoimmune and neoplastic pathologies) affecting the immune 
system; 
• No treatment with drugs affecting the immune system at the 
moment and during the clinical trial; 
• No viral respiratory diseases at the moment of the trial (e.g., 
winter infections). 
Dietary Regimen 
 A commercial synbiotic (YOMO ABC PLUS; Milan, Italy) 
composed by fermented cow milk enriched with L. rhamnosus 
Gorbach and Goldin (LGG
®
) (10
7
 bacteria/90g bottle) and the 
soluble fibers oligofructose was administered twice a day before 
lunch and dinner, respectively, for one month. 
Blood Sampling 
 Peripheral blood was taken immediately before ( T0) and after 
(T1) the synbiotic administration and serum was stored at -80°C 
until use. 
Normal Donors 
 Ten healthy blood donor sera were collected and stored at -
80°C.  
Cytokine Assay 
 Determination of cytokines was run using the multiplexing 
assay in cytofluorometry: Cytometric Bead Array (CBA) (Beckton 
Dickinson Biosciences, San Jose, CA, USA). In particular “CBA 
Human Inflammation kit” was selected to assay Interleukin (IL)-12, 
Tumor Necrosis Factor  (TNF)-, IL-10, IL-6, IL-1 and IL-8. 
The test CBA allows the determination of six different cytokines 
simultaneously in the same sample of serum. Six bead populations 
with distinct fluorescence intensities were coated with capture 
antibodies specific for IL-8, IL-1, IL-6, IL-10, TNF-, and IL-
12p70 proteins. The amount of cytokines linked to beads was 
determined later through incubation with a mixture of antibodies 
conjugated with Phycoerythrin (PE) against the same cytokines but 
without competing with the bead’s antibodies for the same site.  
 Ten l/test of each bead suspension were mixed and washed by 
centrifugation. After, mixed beads were resuspended in an 
appropriate buffer, incubated for 30 min at room temperature (RT) 
and protected from light. Fifty l of mixed beads were transferred 
to each assay tube. Lyophilized standards of human cytokines were 
reconstituted in the appropriate diluent and incubated for 15 min 
and, then, diluted by serial dilutions using the appropriate diluent. 
Standard dilutions and samples were added to the appropriate 
sample tubes (50 μl/tube).  
 The beads and the cytokines, in standard or in serum, were 
incubated for 1.5 h at RT protected from light. After, samples were 
washed with 1ml of wash buffer, centrifuged and added with PE-
detection Antibodies (50 μl/test). So, the beads linked to cytokines, 
in standard or in serum and the PE-conjugated anti-human cyto-
kines were incubated for 1.5 h at RT protected from light and they 
formed a ternary complex (bead-Antibodies-Cytokine-Antibodies). 
After, samples were washed with 1ml of Wash Buffer, centrifuged 
and 300μl of Wash Buffer were added to each assay tube to analyze 
samples. 
 Flow cytometer "FACSCalibur” (Becton Dickinson), "Cell 
Quest Software" program and "CBA Analysis Software” were used. 
Statistical Evaluation 
 Data were analyzed using Graphpad Prism (ver. 5.00) (Gra-
phpad software inc.-San Diego, CA; USA). Data were expressed as 
medians, 25/75 percentiles, and range. Statistical analysis was 
performed with the Kruskal-Wallis test which was used to evaluate 
differences between paired groups. A p value < 0.05 was 
considered significant. 
RESULTS 
 A drop-out of three subjects was recorded during the study 
because of the occurrence of pathologies not related to the dietary 
regimen.  
 No side effects were recorded in the individuals who terminated 
the trial. 
 As indicated in Fig. (1), baseline levels of IL-12 were below 
normal ranges even if a modest trend toward an increase was noted 
at T1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). Serum levels of IL-12 before (To) and after (T1) synbiotic 
administration. The cytometric bead array (CBA) test was used for 
cytokine determination. N=10 normal donors. 
 
 TNF- levels are expressed in Fig. (2), and also in this case a 
trend toward an increase was evident at T1 but values were still 
below normality. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (2). Serum levels of TNF- before (To) and after (T1) synbiotic 
administration. The cytometric bead array (CBA) test was used for 
cytokine determination. N=10 normal donors. 
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 Sera amounts of IL-1 are illustrated in Fig. (3). At To, they are 
still below normality (p0.001) and, despite a significant increase 
(p0.05) at T1, they were still lower than controls. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (3). Serum levels of IL-1 before (To) and after (T1) synbiotic 
administration. The cytometric bead array (CBA) test was used for 
cytokine determination. N=10 normal donors. 
 
 Levels of IL-6 [see Fig. (4)] were higher than controls (p0.01) 
and synbiotic administration tended to further increase its amounts. 
 Baseline values of IL-8 Fig. (5) were higher than controls (p 
<0.001), and, at T1, they significantly (p <0.001) increased.  
 Levels of IL-10 [see Fig. (6)] were lower than controls and, 
despite a slight increase of values at T1, normality was not attained. 
 
 
 
 
 
 
 
 
 
 
 
Fig. (4). Serum levels of IL-6 before (To) and after (T1) synbiotic 
administration. The cytometric bead array (CBA) test was used for 
cytokine determination. N=10 normal donors. 
 
DISCUSSION 
 Ageing is characterized by a severe imbalance between cell 
maintenance and repair systems which ultimately leads to a 
depressed response toward external and internal stimuli [26,27]. In 
particular, impairment of the immune response in elderly, the so-
called immunosenescence, accounts for the high frequency of 
infections and inflammatory events with ageing [28]. In this 
framework, our data clearly demonstrate an impaired immunity in 
the group of free-living elderly enrolled for this study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (5). Serum levels of IL-8 before (To) and after (T1) synbiotic 
administration. The cytometric bead array (CBA) test was used for 
cytokine determination. N=10 normal donors. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (6). Serum levels of IL-10 before (To) and after (T1) synbiotic 
administration. The cytometric bead array (CBA) test was used for 
cytokine determination. N=10 normal donors. 
 
 In our subjects, the reduced levels of serum IL-12 indicate the 
incapability of the aged host to skew the adaptive immune response 
toward the Th1 pathway. Similar results have been published by 
Stout-Delgado and associates [29] who observed an impairment of 
plasmacytoid DCs with reduced release of interferon- and IL-12 in 
response to bacterial stimuli. This fact may contribute to the 
increased frequency of infections reported in aged humans. 
However, also the bone marrow lymphopoiesis is impaired in aging 
with a profound decline of B cell development, which seems to be 
sex steroid dependent [30]. Therefore, this immune defect may 
account for recurrent infections in elderly, too.  
 Quite interestingly, the reduced activation of the TH1 pathway 
by IL-12 is complicated by a profound immune dysfunction of the 
aged T cell compartment [31]. In fact, thymus atrophy and 
reduction of naïve T cells lead to a dramatic shrinkage of the T cell 
repertoire being responses directed against ubiquitary infectious 
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pathogens [31]. This fact indicates the complexity of immune 
disorders in aging. 
 In the present study proinflammatory cytokines, such as TNF- 
and, mostly, IL-1 are detectable in minute amounts, thus 
indicating a deficit of innate immunity, as reported by others [32]. 
In addition another study reported the negative effects of aging on 
in vitro Toll-Like Receptor-mediated proinflammatory responses in 
macrophages [33]. The consequential lack of proinflammatory 
cytokine secretion seems to further aggravate the age related 
decline in T cell function and this has been overcome by the use of 
proinflammatory adjuvants in mice [34]. 
 On the other hand, the IL-10 mediated antinflammatory 
response is also reduced in our aged group in comparison with the 
young counterpart. In this framework, according to Henson and 
associates [35] inhibitory molecules, such as CTLA-4 and PD-1, 
can deliver negative signals able to alter the balance between T cell 
activation and tolerance. 
 Strikingly, the acute phase response is more preserved in these 
aged subjects either in terms of IL-6 or of IL-8 amounts. Especially 
IL-8 values are higher than the younger counter part and neutrophil 
chomotaxis may afford protection to the host in the acute phase of 
inflammatory processes. 
 Quite interestingly, synbiotic administration leads to an increase 
of IL-1 and IL-6 in a significant manner. However, the best result 
is evident in the case of IL-8, whose levels continue to increase 
despite higher baseline values than controls.  
 On the other hand, in the case of IL-12, TNF- and IL-10 a 
slight trend to increase was observed at T1. Previous reports have 
pointed out the ability of L. casei to favor the Th1-type response via 
release of IL-12 by macrophages [36]. In our case, the trend to 
increase in IL-10, even if modest, in concomitance with that of IL-
12 may maintain the IL-10: IL-12 ratio in equilibrium, thus eliciting 
protective effects as observed in a murine model of experimental 
colitis [37-39]. This probiotic-dependent effect seems to be 
mediated via inhibition of the NF-KB pathway, thus leading to 
suppression of inflammatory response [40]. In this regard, in a 
recent report Schiffrin and associates [41] have demonstrated that 
probiotic administration in healthy elderly could normalize the 
response to endotoxins reducing low-grade inflammation. 
 In the light of the results obtained through this pilot study, 
increase in dosage and prolongation of synbiotic administration are 
required in order to attain better results mostly in terms of adaptive 
response improvement. At the same time, a melioration of clinical 
manifestations (e.g., reduction of winter infections) should be 
followed-up in elderly in order to support the laboratory findings 
[42]. 
 Finally, in this context other immune therapies under study 
should be mentioned for age-related diseases, such as vaccination 
against shingles, Alzheimer’s disease and atherosclerosis [43]. 
Furthermore, due to the complexity of processes leading to 
immunosenescence [44-46] a series of vaccines against bacterial 
and viral infectious diseases has recently been developed [47]. 
Since vaccination in aging is not very efficacious because of the 
impaired immune response, all therapeutical measures aimed at 
modulating the immune balance, even including administration of 
synbiotics, should be pursued. 
 In conclusion, in vitro investigations as well as clinical trials in 
free-living elderly are important for a better understanding of those 
mechanisms responsible for immunosenescence. 
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